Time to diagnosis from onset of RF is significantly shorter in diffuse SSc. Although mRS is typically higher in diffuse SSc, no correlation has been found between mRS and time to diagnosis. Therefore, duration of diagnosis may be influenced by internal organ involvement and other complications rather than skin changes due to lack of awareness of physicians about SSc related early skin changes. Referral to a proper physician by a familier healthcare practitioner decreased the number of physicians attending till the diagnosis, although it did not affect the time to diagnosis. Background: Immune system activation with associated up-regulation in the production of extra-cellular matrix proteins by fibroblasts are known specific features in the pathogenesis of systemic scleroderma (SSc). Most recent data indicate that MCP-1 and MCP-3 chemokines from the family of monocyte chemoattractant proteins are also involved into SSc pathogenetic process. Creactive protein (CRP) is known as the marker of acute-phase inflammation. The association between increased CRP levels and SSc clinical and serological parameters has been reported recently. Objectives: To study the association between -2518 A/G gene polymorphism, encoding MCP-1, and CRP levels in different clinical SSc phenotypes in the Russian cohort of pts. Methods: PCR-RFLP method was used to identify MCP-1 genotype in 81 SSc pts aged 49,4±12,6 years, with mean SSc duration 11,1±9,0 years. CRP concentrations were measured with highly sensitive immunoturbidimertry method. Results: CRP levels were correlated with MCP-1 genotypes in pts with limited (lcSSc) and diffuse (dcSSc) phenotypes, with interstitial lung disease (ILD+), with SSc duration >3 years, with increased CRP level (>5 mg/L), with positive antibody titers to DNA topoisomerase I (ATA+) and antibody to centromeres (ACA+). A total cohort analysis showed that carriers of -2518AA genotype had higher mean CRP level versus G allele carriers (12,6±7,5 mg/L vs 4,9±4,8 mg/L, respectively, p=0,009), although similar trend was found in dcSSc phenotype (16,4±19,5 mg/L vs 6,1±4,4 mg/L, respectively, p=0,040). In pts with -2518AA genotype and SSc duration >3 years mean CRP level was significantly higher than in G allele carriers (1,1±16,7 mg/L vs 4,5±4,4 mg/L, respectively, p=0,025). In (ILD+) and (ATA+) subgroup pts with -2518AA genotype demonstrated higher mean CRP levels as compared to G allele carriers (12,4±15,6 mg/L vs 5,5±5,1 mg/L, respectively, p=0,018; and 17,6±20,9 mg/L vs 5,5±5,5 mg/L, respectively, p=0,010). CRP levels (>5 mg/L) were found in 31 (38%) pts and were significantly different between AA genotype carriers and G allele carriers (27,4±19,2 mg/L vs 10, 4±3,8 mg/L, respectively, p=0,003). No associations between genetic variations in the MCP-1 gene and CRP levels in lcSSc phenotype, SSc duration <3 years, CRP levels <5mg/L and (ACA+) pts were established. Conclusions: Our data demonstrate that -2518A/G MCP-1 gene polymorphism is closely associated with CRP levels, thus, it can be considered as a new marker, reflecting the severity of the disease and unfavorable SSc prognosis.
AB0660 CHARACTERISTICS OF AL-l LIGHT-CHAIN AND AMYLOID A DEPOSITION IN PROGRESSIVE SYSTEMIC SCLEROSIS -A COMPARATIVE POSTMORTEM CLINICOPATHOLOGIC STUDY OF 12 PATIENTS
Conclusions: In SSc patients the prevalence and extent of l light-chain and amyloid A deposits on different tissue structures changed parallel. The higher prevalence and extent of l light-chain deposits in contrast to amyloid A may be explained with qualitative differences of l light-chain and amyloid A; l light-chain seems to have greater affinity for tissues than amyloid A protein.
Infiltration of the vessel walls -regarding the amount of l light-chain and amyloid A deposits in arterioles and arteries in contrast to the veins -showed a converse tendency in SSc patients with AL-l or AAa. This may be related to sluggish blood flow or stasis (backward congestion and accumulation of circulating precursors) in both diseases. Background: Systemic sclerosis (SSc) is associated with decreased saliva production and interincisal distance, more missing teeth, and periodontal disease. Orofacial manifestations of SSc contribute greatly to overall disease burden and still are regularly overlooked and under-treated. Previous studies did not confirm correlation between disease severity and oral health-related quality of life in SSc patients.
